n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Pancreatitis in 1 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Pancreatitis: INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.
Excerpt | Relevance | Reference |
---|---|---|
" Male and female rats dosed at 536." | 5.39 | Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. ( Che, JH; Cho, WS; Cho, Y; Jang, A; Jeong, J; Kang, BC; Kim, H; Kim, T; Ko, S; Lee, JK; Na, Y; Park, JS; Seok, SH; You, JR, 2013) |
" Male and female rats dosed at 536." | 1.39 | Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions. ( Che, JH; Cho, WS; Cho, Y; Jang, A; Jeong, J; Kang, BC; Kim, H; Kim, T; Ko, S; Lee, JK; Na, Y; Park, JS; Seok, SH; You, JR, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seok, SH | 1 |
Cho, WS | 1 |
Park, JS | 1 |
Na, Y | 1 |
Jang, A | 1 |
Kim, H | 1 |
Cho, Y | 1 |
Kim, T | 1 |
You, JR | 1 |
Ko, S | 1 |
Kang, BC | 1 |
Lee, JK | 1 |
Jeong, J | 1 |
Che, JH | 1 |
1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Pancreatitis
Article | Year |
---|---|
Rat pancreatitis produced by 13-week administration of zinc oxide nanoparticles: biopersistence of nanoparticles and possible solutions.
Topics: Administration, Oral; Animals; Carcinogens; Cell Line, Tumor; Cell Proliferation; Chelating Agents; | 2013 |